Finally,
MPO reduces nitric oxide (NO) bioavailability by a number of
mechanisms including direct consumption of NO and production
of reactive oxygen species that oxidize tetrahydrobiopterin to its
inactive form, which, in turn, uncouples endothelial NO synthase.